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Abstract
Background: The attendance rate in Estonian cervical cancer screening programme is too low therefore the
programme is hardly effective. A cross-sectional population based survey was performed to identify awareness of
cervical cancer risk factors, reasons why women do not want to participate in cervical screening programme and
wishes for better organisation of the programme.
Method: An anonymous questionnaire with a covering letter and a prepaid envelope was sent together with the
screening invitation to 2942 randomly selected women. Results are based on the analysis of 1054 (36%) returned
questionnaires.
Results: Main reasons for non-participation in the national screening programme were a recent visit to a
gynaecologist (42.3%), fear to give a Pap-smear (14.3%), long appointment queues (12.9%) and unsuitable
reception hours (11.8%). Fear to give a Pap-smear was higher among women aged 30 and 35 than 50 and 55 (RR
1.46; 95% CI: 0.82-2.59) and women with one or no deliveries (RR 1.56, 95% CI: 0.94-2.58). In general, awareness of
cervical cancer risk factors is poor and it does not depend on socio-demographic factors. Awareness of screening
was higher among Estonians than Russians (RR 1.64, 95% CI: 1.46-1.86). Most women prefer to receive information
about screening from personally mailed invitation letters (74.8%).
Conclusions: Women need more information about cervical cancer risk factors and the screening programme.
They prefer personally addressed information sharing. Minority groups should be addressed in their own language.
A better collaboration with service providers and discouraging smears outside the programme are also required.
Keywords: cervical cancer screening, Estonia, reasons for non-participation
Background
Estonia is one of the countries in Eastern Europe with
t h eh i g h e s ti n c i d e n c ea n dm o r t a l i t yr a t e sf o rc e r v i c a l
cancer. In the year 2008, the estimated world age stan-
dardised incidence rate of cervical cancer was 19.1 per
100, 000 women-years in Estonia with 151 new cervical
cancer cases being detected [1,2]. The 5-year age-stan-
dardised relative survival among cervical cancer patients
diagnosed from 1990 to 1994 is 63% in Europe, and 53%
for Estonia [3]. In last 25 years, the cervical cancer inci-
dence and mortality rate in Estonia have not decreased
[4]. Every year about 143-190 new cervical cancer cases
are detected and about 70 women die from this disease
(Estonian Cancer Registry, unpublished data). Among all
malignant tumours, cervical cancer is the one which can
be most effectively controlled by organised screening
programmes [5]. Previous studies have concluded that
the lack of cervical smear history or poorly validated
screening services [6] is the major reason why the dis-
ease still occurs [7].
Organised nationwide screening for cervical cancer
was started in Estonia in 2006, before that, pilot studies
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group of 30 to 59 with health insurance get invitations
to screening with a 5 year-interval after a negative test.
Women diagnosed with cervical cancer, women with-
out health insurance and women for whom the Pap-
test has been reimbursed in the last 12 months are
excluded from the list of invitees. In 2010 there were
8.1% of women at age 30 to 59 without health insur-
ance- most of them long term unemployed. Trained
midwives take Pap-tests of the programme in 19 clinics
all over Estonia and cytological analyses are made in 7
laboratories. In order to get the results, women have
to contact the clinic on a certain date and time [8].
The major problem is low participation in the screen-
ing programme. In 2006, the attendance rate was
20.7% [9], and it slowly increased to 36% in 2009. Pap-
smears taken within organised screening programme
constitute less than 10% of all tests, most of the Pap-
tests are taken by gynaecologists during a regular
health control. But an organised screening programme
can reduce incidence and mortality by 80% [10] as
shown in other European countries. Another major
shortcoming of the system is the lack of an electronic
screening registry, which would make it easier to col-
lect test results and monitor women with an abnormal
smear.
The present article shows results of a survey addressed
to women who were invited to a cervical screening pro-
gramme in order to obtain information on their aware-
ness about cervical cancer risk factors and screening,
wishes for better organisation of the screening pro-
gramme, and reasons for non-attendance in the orga-
nised screening programme.
Methods
Sample and data collection
In 2010, the Estonian Health Insurance Fund mailed 37,
275 personal invitations to women aged 30 to 55 to par-
ticipate in a cervical cancer screening programme. Invi-
tations, based on the data from the Estonian Population
Registry, were sent to women born in 1955, 1960, 1965,
1970, 1975, and 1985. Of those women, a random sam-
ple of 3, 047 was selected to receive an anonymous
questionnaire with the invitation. For various reasons,
t h eq u e s t i o n n a i r e sw e r en o ts e n to u tt oa l lw o m e n :3 9
w o m e nw e r ee x c l u d e db e c a u s et h e yh a dl o s th e a l t h
insurance, 3 women had died and 63 women had an
incomplete address in the Population Registry. For ran-
domisation we used women’s study identification num-
bers in Excel randomization system. By comparison of
socio-demographic characteristics (age, ethnicity and
place of residence) between the sample and Statistics
E s t o n i ap o p u l a t i o nd a t aw ec o n s i d e r e dt h i ss a m p l e
representative.
The final sample comprised 2, 942 women who
received a questionnaire and a prepaid envelope with a
screening invitation. All women got questionnaires both
in the Estonian and in the Russian language. Question-
naires and invitations were posted between 29 March
and 2 April 2010. In December 2010, 1, 600 question-
naires with reminders were mailed to women who had
not attended the screening programme after the first
mailing. To check who had already participated in the
screening programme, personal identification codes of
the women included in the sample were linked with the
Estonian Health Insurance Fund database. Women who
had already fulfilled the questionnaire first time and
received it again, were asked to ignore it.
The questionnaire included 21 questions and was
divided into four sections (additional file 1): awareness
about cervical cancer screening and risk factors for cer-
vical cancer; reasons for non-participation in the
national cervical cancer screening programme; women’s
preferences for the organisation of the cervical cancer
screening programme; socio-demographic background
data of the respondents [11]. The study design was
approved by the Tallinn Medical Ethics Committee.
Data analysis
For statistical analysis software package STATA 10 was
used.
Basic descriptive statistics and frequencies were ana-
lysed for all variables.
Relative risk ratios were estimated by log-binomial
regression to assess the association between knowledge
of the screening programme, knowledge of cervical can-
cer risk factors, and reasons for non-participation
(dependent variables) and socio-demographic character-
istics (independent variables) that include mother ton-
gue/ethnicity, place of residence, age, and number of
children.
The “ethnicity” variable was categorised into 2 groups:
Estonians and non-Estonians (the latter consisted of
mainly Russian speaking population). Russian-speaking
women are those who returned the questionnaire in
Russian. Place of residence was also coded as a binary
variable: urban areas (big cities and small towns) and
rural areas (villages and settings). For certain analyses,
age-groups of 30 and 35, 40 and 45, 50 and 55 were
combined, respectively.
Results
A total of 2, 942 questionnaires were mailed and after a
reminder, 1, 054 women (36%) returned the completed
questionnaire. The mean age of the respondents was 43
years; 74.3% were married or cohabiting, 10.5% were
single and 14.5% were widowed or divorced; 69.1% were
Estonian; 76.9% were working, 10.4% were housewives,
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urban areas (Table 1). From background characteristics,
it was possible to compare respondents and non-respon-
dents only by age, and there was no difference between
these two groups in that respect (data not shown).
72.3% of the women answered that they were aware of
the cervical cancer screening programme. In the
adjusted model screening awareness depended on ethni-
city - Estonian-speaking women were better aware of
the programme than the others (RR 1.64; 95% CI: 1.46-
1.86). Women with more than two deliveries had a
slightly better knowledge about screening (RR 1.09; 95%
CI: 1.00-1.18) (Table 2).
In the questionnaire all the cervical cancer risk factors
were given without stating this and women were asked
whether they think that these are risk factors or not.
Women did not have a good overview of the impact of
smoking as a cause of cervical cancer - only 49.2% of
the women marked this as a risk factor. HPV was better
known as a risk factor - 76.6% of the women marked it
(Figure 1). Awareness of the risk factors for cervical can-
cer did not depend on socio-demographic factors (data
not shown).
75.7% of the women responded that they were plan-
ning to participate in a cervical cancer screening pro-
gramme. The wish to participate in the screening
programme tended to be higher in the older age groups
(Table 3).
Among the respondents, 254 (24.3%) women answered
that they were not planning to participate in the cervical
cancer screening programme. Next we asked more gen-
eral questions regarding all possible reasons for women’s
non-attendance and not only for non-attendance in this
particular year. 41.9% (442) of the women pointed out
different reasons why they could not participate in
s c r e e n i n g .T h em o s tc o m m o nr e a s o nf o rt h i sw a sa
recent health control at a gynaecologist (42.3%). Other
reasons were fear to give a Pap-smear (14.3%), long
waiting list for appointment (12.9), clinic is far away
(12.7) and unsuitable reception times (11.8%). Approxi-
mately 58.1% of the women did not answer this ques-
tion, (Table 4).
A recent visit to a gynaecologist was more likely the
reason for non-participation in the screening pro-
gramme among Estonian than non-Estonian women (RR
2.00, CI 95%: 1.39-2.88) and married/cohabiting women
(RR 1.67, CI 95%: 1.17-2.38). The wish not to attend
was not associated with place of residence or a recent
visit to a gynaecologist.
Fear to give the Pap-smear was higher among 30- and
35-year-old women than in 50- and 55-year-old women
(RR 1.50, 95% CI: 0.81-2.78). Estonian women found it
more likely than others that appointment times are not
suitable (RR 5.76; 95% CI: 2.08-16.04), the same was
found for women from urban areas (RR 1.98; 95% CI:
1.05-3.76). Women from urban areas also found
appointment queues too long (RR 1.64, 95% CI: 0.86-
3.13).
Most women prefer the current system to register by
phone for the reception to give the Pap-smear (83.2%).
13.0% prefer to register by e-mail and nearly as many
women (10.4%) expressed their wish to register by web-
page. Women prefer to give a Pap-smear at a women’s
clinic rather than at a general practitioner (92.1%). To
Table 1 Socio-demographic characteristics of women
participating in the study
Variable N = 1054 Proportion (%)
Age group, yrs
30 130 12.5
35 155 14.9
40 168 16.2
45 173 16.7
50 194 18.7
55 217 20.9
Missing 17 1.6
Ethnicity/mother tonge
Estonian 728 69.1
Non-Estonian* 308 29.2
Missing 18 1.7
Marital status
Married or cohabiting 783 74.3
Single 111 10.5
Divorced/widowed 158 14.5
Missing 2 0.2
Occupational situation
Working 811 76.9
House wife 110 10.4
Student 6 0.6
Retired 38 3.6
Unemployed 87 8.3
Missing 2 0.2
Place of residence
Urban 728 69.0
Rural 322 30.5
Missing 4 0.4
Number of children
0 121 11.6
1 254 24.3
2 459 43.8
3 157 15.0
≥4 56 5.4
Missing 7 0.7
* mainly Russian speaking population
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(33.9%) and e-mail (34.3%). The most uncomfortable
method to get results was stated to be by SMS (3.9%).
Most of the women (74.8%) expect to receive informa-
tion about cervical cancer screening programme from
personally sent invitations with information leaflets. 18%
prefer thematic articles and advertisements in women’s
magazines and 19% would like to get information from
family practitioners. Only 9.8% prefer advertisements on
television, and 5.8% prefer to receive no information.
89% of the women would feel happy to receive remin-
ders from their general practitioner to participate in the
screening.
Discussion
This study had three principal aims. First, to estimate
which socio-economic characteristics are associated with
limited knowledge about cervical cancer screening pro-
gramme and risk factors for cervical cancer. Secondly,
to investigate reasons why so many Estonian women do
not participate in the cervical cancer screening pro-
gramme. And finally, to study women’s preferences for
better organisation of the screening programme.
An important outcome of our study was that approxi-
mately a quarter of the respondents were not at all or
were only partially aware of cervical cancer screening.
According to other studies, the awareness was lower
Table 2 Women’s awareness of cervical cancer screening programme in Estonia
Socio-demographic characteristics N (yes/no) RR(CI 95%) Adjusted* RR (CI 95%)
Age group, yrs
30 and 35 198/87 1 1
40 and 45 257/83 1.08 (0.99-1.20) 1.04 (0.95-1.14)
50 and 55 291/12 1.02 (0.92-1.13) 1.04(0.96-1.14)
Ethnicity/mother tongue
Non-Estonian 152/156 1 1
Estonian 593/134 1.65 (1.47-1.86) 1.64 (1.46-1.86)
Place of residence
Urban 498/229 1 1
Rural 259/63 1.17 (1.09-1.26) 1.02 (0.96-1.10)
Number of children
0-1 248/126 1 1
≥2 505/167 1.13 (1.04-1.23) 1.09 (1.00-1.18)
* Adjusted for all the dependent variables: age, ethnicity/mother tongue, place of residence, number of children.
Figure 1 Estonian women’s awareness of cervical cancer risk factors (N = 1054), 2010.
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sian-speaking respondents were less aware of the screen-
ing, although invitations and information sheets are
bilingual.
The study results revealed that there is a strong need
to improve women’s knowledge about cervical cancer
risk factors. Women do not know enough about the
main cervical cancer risk factors, particularly low is
knowledge about the impact of smoking. Still, knowl-
edge about cervical cancer risk factors is higher than
many other studies published to date [12].
Our study results show that most respondents were
satisfied with the present organisation of the screening
programme. Most respondents prefer to have the Pap-
smear taken by a gynaecologist or a midwife rather than
by general practitioners, the way it has been arranged in
Estonia. Additionally, over 90% of them are happy if
general practitioners or nurses remind them to
participate in the screening programme. Women prefer
to register for screening by phone, but would like to
learn about the results equally well by either phone or
e-mail thus, to use e-mail for delivering results should
be considered. Women prefer personally addressed
information sharing, i.e. personal invitations with infor-
mation leaflets. Although some studies have shown that
giving the appointment time and place readily in the
invitation letter would increase attendance [13], there is
no need to do it Estonia because women are satisfied
with the current system. Still, there might be a need to
do some additional organisational changes regarding the
screening programme, for example, routinely sending a
reminder to all non-attenders, which has not been done
in Estonia regularly although a systematic review shows
its effectiveness [14], and also self-sampling could be
tried [15].
According to our results, the main reason why women
do not attend the screening programme is a recent visit
to a gynaecologist (42.3%). This shows a clear need to
improve collaboration between service providers and
discourage Pap-smears outside the organised screening
programme. Also, another very important reason for
non-attendance needs to be noticed - women have fear
to give Pap-smears. Previous studies have also shown
that the fear to give Pap-smear is one barrier for screen-
ing [16]. According to this result, we are not able to say
exactly what this fear means to women - whether it is
fear for cancer or fear for Pap-smear procedure, but
there is a clear need to better inform women about the
screening procedure and cervical cancer. Some earlier
studies have shown that women who do not attend
screening have higher fear and anxiety for cancer [17].
Women from urban areas pointed out unsuitable
appointment times and too long appointment queues,
which could mean that health service availability is not
good enough in urban areas. More resources need to be
addressed to develop invitational and sample-taking
activities and units. Yet there is no available data of how
many women actually attended a screening after receiv-
ing a remainder.
Our study had some limitations. One of the most
important shortcomings of this survey was the low
response rate, probably concerning especially women
who are not planning to participate in screening. This is
a common problem in studies among non-attenders or
in a population with a very low attendance rate in
screening. In the early stage of planning the study, we
had to consider the fact that women who are most likely
to respond to the questionnaire are the ones who wish
to participate in the screening or have already been to a
gynaecologist - because they have more interest in the
subject. This tendency has been noted in several studies
before [18]. Another problem was that women often did
Table 3 Wish to participate in cervical cancer screening
programme among Estonian women, 2010
Variable N (yes/no) RR (95%CI) Adjusted*RR
(95%CI)
Age group, yrs
30 and 35 206/76 1 1
40 and 45 276/65 1.12 (1.07-2.28) 1.13 (1.03-1.23)
50 and 55 302/10 1.06 (0.75-1.50) 1.03 (0.93-1.13)
Ethnicity/mother tongue
Estonian 547/175 1 1
Non-Estonian 233/74 1.00 (0.93-1.08) 1.02 (0.94-1.10)
Place of residence
Urban 550/174 1 1
Rural 241/78 0.99 (0.92-1.07) 1.02 (0.94-1.11)
Number of children
0-1 281/93 1 1
≥2 508/158 1.02 (0.94-1.09) 0.99 (0.92-1.06)
* Adjusted for all the dependent variables: age, ethnicity/mother tongue,
place of residence, number of children.
Table 4 Reasons for non-attendance in the cervical
cancer screening programme (N = 442)
Reasons N %
Recent visit to gynaecologist 187 42.3
Fear to give Pap-smear 63 14.3
Waiting list is too long 57 12.9
Clinic is far away 56 12.7
Appointment times not suitable 52 11.8
Do not have time 46 10.4
Uterus is removed 36 8.14
It is not necessary for me 9 2.0
Other reasons 52 11.8
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attendance.
Also, the education level was not asked from respon-
dents, but earlier studies have shown important associa-
tion between health behaviour and educational level
[19].
Conclusion
There is a clear need for better information sharing
about cervical cancer risk factors and screening in the
total screening population. Russian-speaking women,
older women and women with a smaller number or no
deliveries need special attention. To increase effective-
ness of the program and reduce cervical cancer burden,
there is a need to decrease Pap-smears taken outside
screening program. Special attention should be paid to
availability of screening services in urban areas. Instead
of big information campaigns, women in Estonia prefer
individualised and delicate information sharing; this
should be taken into account while tailoring the cam-
paigns and invitations.
Additional material
Additonal file 1: Questionnare used for survey Women’s knowledge
about cervical cancer risk factors, screening, and reasons for non-
participation in cervical cancer screening programme in Estonia.
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